ZFHX CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. ZFHX Gen Silencer sind erhältlich als ZFHX CRISPR/Cas9 Knockout Plasmide und ZFHX Double Nickase Plasmide. ZFHX CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
ZFHX CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ZFHX2 CRISPR/Cas9 KO Plasmid (h) | sc-416287 | h | Gene Knockout | GFP | 0 | ||
ZFHX2 HDR Plasmid (h) | sc-416287-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ZFHX2 Double Nickase Plasmid (h) | sc-416287-NIC | h | Gene Knockout | Puromycin | 0 | ||
ZFHX2 Double Nickase Plasmid (h2) | sc-416287-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ZFHX2 CRISPR/Cas9 KO Plasmid (m) | sc-433662 | m | Gene Knockout | GFP | 0 | ||
ZFHX2 HDR Plasmid (m) | sc-433662-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ZFHX2 Double Nickase Plasmid (m) | sc-433662-NIC | m | Gene Knockout | Puromycin | 0 | ||
ZFHX2 Double Nickase Plasmid (m2) | sc-433662-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ZFHX4 CRISPR/Cas9 KO Plasmid (h) | sc-408957 | h | Gene Knockout | GFP | 0 | ||
ZFHX4 HDR Plasmid (h) | sc-408957-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ZFHX4 Double Nickase Plasmid (h) | sc-408957-NIC | h | Gene Knockout | Puromycin | 0 | ||
ZFHX4 Double Nickase Plasmid (h2) | sc-408957-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ZFHX4 CRISPR/Cas9 KO Plasmid (m) | sc-429838 | m | Gene Knockout | GFP | 0 | ||
ZFHX4 HDR Plasmid (m) | sc-429838-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ZFHX4 Double Nickase Plasmid (m) | sc-429838-NIC | m | Gene Knockout | Puromycin | 0 | ||
ZFHX4 Double Nickase Plasmid (m2) | sc-429838-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ZFHX CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ZFHX2 CRISPR Activation Plasmid (h) | sc-416287-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 CRISPR Activation Plasmid (h2) | sc-416287-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 Lentiviral Activation Particles (h) | sc-416287-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 Lentiviral Activation Particles (h2) | sc-416287-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 CRISPR Activation Plasmid (m) | sc-433662-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 CRISPR Activation Plasmid (m2) | sc-433662-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 Lentiviral Activation Particles (m) | sc-433662-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX2 Lentiviral Activation Particles (m2) | sc-433662-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 CRISPR Activation Plasmid (h) | sc-408957-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 CRISPR Activation Plasmid (h2) | sc-408957-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 Lentiviral Activation Particles (h) | sc-408957-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 Lentiviral Activation Particles (h2) | sc-408957-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 CRISPR Activation Plasmid (m) | sc-429838-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 CRISPR Activation Plasmid (m2) | sc-429838-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 Lentiviral Activation Particles (m) | sc-429838-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ZFHX4 Lentiviral Activation Particles (m2) | sc-429838-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |